Limaca Medical is developing the Precision-GI™ endoscopic ultrasound-guided biopsy device, which utilizes a motorized, automated cutting mechanism to enhance tissue acquisition for histological and genetic testing. This technology addresses the high non-diagnostic rates and variability in biopsy quality associated with traditional manual biopsy methods, enabling faster, more consistent results across varying physician skill levels.
Funding
$3.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional endoscopic ultrasound-guided biopsies often yield non-diagnostic results due to limitations of manual techniques, high operator skill dependency, and inconsistent tissue sample quality. These limitations can lead to delayed diagnoses, repeat procedures, and suboptimal tissue samples for histological and genetic testing, hindering precision medicine approaches.
Solution
Limaca Medical's Precision-GI™ is an endoscopic ultrasound (EUS) biopsy device that utilizes a motorized, automated, rotating cutting mechanism to improve tissue acquisition. The device is designed to obtain superior volume and quality tissue samples in a single pass, reducing blood content and saving procedure time. By automating the biopsy process, Precision-GI™ aims to standardize outcomes across varying physician skill levels, providing consistent and high-quality tissue samples suitable for histopathologic and molecular analysis. The device has received FDA clearance for endoscopic ultrasound-guided biopsy procedures.
Target Audience
The primary target audience includes gastroenterologists, hepatologists, and pulmonologists who perform endoscopic ultrasound-guided biopsies for the diagnosis and treatment of pancreatic, liver, and lung cancers.
Features
- Motorized, automated, rotating cutting mechanism for consistent tissue acquisition
- Single-pass core biopsy, obtaining 2-3 controlled cores
- Reduced blood content in samples
- Standardized outcomes, minimizing variability across different physician skill levels
- Contiguous 110mm core biopsy sample
- Intact, voluminous, preserved tissue samples suitable for cyto- and histopathologic diagnoses, and molecular tumor profiling